197 related articles for article (PubMed ID: 17408540)
1. [Rituximab for treatment of patients with systemic autoimmune diseases].
García Hernández FJ; Ocaña Medina C; González León R; Garrido Rasco R; Colorado Bonilla R; Castillo Palma MJ; Sánchez Román J
Med Clin (Barc); 2007 Mar; 128(12):458-62. PubMed ID: 17408540
[TBL] [Abstract][Full Text] [Related]
2. Adjunction of rituximab to steroids and immunosuppressants for refractory/relapsing Wegener's granulomatosis: a study on 8 patients.
Brihaye B; Aouba A; Pagnoux C; Cohen P; Lacassin F; Guillevin L
Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S23-7. PubMed ID: 17428359
[TBL] [Abstract][Full Text] [Related]
3. [Rituximab treatment for immune thrombocytopenia associated with systemic lupus erythematosus].
Lehembre S; Macario-Barrel A; Musette P; Carvalho P; Joly P
Ann Dermatol Venereol; 2006 Jan; 133(1):53-5. PubMed ID: 16495854
[TBL] [Abstract][Full Text] [Related]
4. [Treatment with rituximab of autoimmune disease: results from AADEA's registry].
Callejas Rubio JL; Camps MT; García-Hernández F;
Med Clin (Barc); 2008 Jan; 130(2):79. PubMed ID: 18221681
[No Abstract] [Full Text] [Related]
5. Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations.
Aries PM; Hellmich B; Voswinkel J; Both M; Nölle B; Holl-Ulrich K; Lamprecht P; Gross WL
Ann Rheum Dis; 2006 Jul; 65(7):853-8. PubMed ID: 16269425
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of ANCA-associated vascularitides].
Guillevin L; Pagnoux C
Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
[TBL] [Abstract][Full Text] [Related]
7. Treatment of refractory retrobulbar granuloma with rituximab in a patient with ANCA-negative Wegener's granulomatosis: a case report.
Ooka S; Maeda A; Ito H; Omata M; Yamada H; Ozaki S
Mod Rheumatol; 2009; 19(1):80-3. PubMed ID: 18806927
[TBL] [Abstract][Full Text] [Related]
8. Low-dose rituximab therapy in steroid-refractory thrombocytopenia due to systemic lupus erythematosus.
Ilizaliturri-Guerra O; Uriarte-Botello R; Pineda-Sic RÁ; Serna-Peña G; Garza-Elizondo MA; Galarza-Delgado DÁ; Leal-Bramasco AS; Elizondo-Solís CV; Santoyo-Fexas L; Villarreal-Alarcón MÁ
Rheumatol Int; 2020 Oct; 40(10):1717-1724. PubMed ID: 32797277
[TBL] [Abstract][Full Text] [Related]
9. Rituximab in refractory ophthalmic Wegener's granulomatosis: PR3 titers may predict relapse, but repeat treatment can be effective.
Joshi L; Lightman SL; Salama AD; Shirodkar AL; Pusey CD; Taylor SR
Ophthalmology; 2011 Dec; 118(12):2498-503. PubMed ID: 21907416
[TBL] [Abstract][Full Text] [Related]
10. Infliximab or rituximab for refractory Wegener's granulomatosis: long-term follow up. A prospective randomised multicentre study on 17 patients.
de Menthon M; Cohen P; Pagnoux C; Buchler M; Sibilia J; Détrée F; Gayraud M; Khellaf M; Penalba C; Legallicier B; Mouthon L; Guillevin L
Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S63-71. PubMed ID: 21586199
[TBL] [Abstract][Full Text] [Related]
11. Effective B cell depletion with rituximab in the treatment of autoimmune diseases.
Kneitz C; Wilhelm M; Tony HP
Immunobiology; 2002 Dec; 206(5):519-27. PubMed ID: 12607727
[TBL] [Abstract][Full Text] [Related]
12. Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy.
Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Baldovino S; Menegatti E; La Grotta R; Modena V
Nephrol Dial Transplant; 2011 Dec; 26(12):3987-92. PubMed ID: 21385860
[TBL] [Abstract][Full Text] [Related]
13. Anti-CD20 therapy of treatment-resistant Wegener's granulomatosis: favourable but temporary response.
Omdal R; Wildhagen K; Hansen T; Gunnarsson R; Kristoffersen G
Scand J Rheumatol; 2005; 34(3):229-32. PubMed ID: 16134730
[TBL] [Abstract][Full Text] [Related]
14. Rituximab in refractory autoimmune diseases: Brazilian experience with 29 patients (2002-2004).
Scheinberg M; Hamerschlak N; Kutner JM; Ribeiro AA; Ferreira E; Goldenberg J; Kiss MH; Chahade WH
Clin Exp Rheumatol; 2006; 24(1):65-9. PubMed ID: 16539821
[TBL] [Abstract][Full Text] [Related]
15. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial.
Keogh KA; Ytterberg SR; Fervenza FC; Carlson KA; Schroeder DR; Specks U
Am J Respir Crit Care Med; 2006 Jan; 173(2):180-7. PubMed ID: 16224107
[TBL] [Abstract][Full Text] [Related]
16. Rituximab is an alternative in a case of contra-indication of cyclophosphamide in Wegener's granulomatosis.
Bachmeyer C; Cadranel JF; Demontis R
Nephrol Dial Transplant; 2005 Jun; 20(6):1274. PubMed ID: 15840659
[No Abstract] [Full Text] [Related]
17. Rituximab for treatment-resistant extensive Wegener's granulomatosis--additive effects of a maintenance treatment with leflunomide.
Henes JC; Fritz J; Koch S; Klein R; Horger M; Risler T; Kanz L; Koetter I
Clin Rheumatol; 2007 Oct; 26(10):1711-5. PubMed ID: 17502992
[TBL] [Abstract][Full Text] [Related]
18. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
[TBL] [Abstract][Full Text] [Related]
19. Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients.
Calich AL; Puéchal X; Pugnet G; London J; Terrier B; Charles P; Mouthon L; Guillevin L;
J Autoimmun; 2014 May; 50():135-41. PubMed ID: 24703438
[TBL] [Abstract][Full Text] [Related]
20. Rituximab in the treatment of refractory scleritis in patients with granulomatosis with polyangiitis (Wegener's).
Recillas-Gispert C; Serna-Ojeda JC; Flores-Suárez LF
Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2279-84. PubMed ID: 26507398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]